DexCom (NASDAQ:DXCM – Get Rating) had its price objective hoisted by Raymond James from $101.00 to $125.00 in a report released on Friday, Benzinga reports. The firm currently has an outperform rating on the medical device company’s stock. A number of other equities analysts also recently issued reports on the company. Cowen increased their price […]
/PRNewswire/ The Global Diabetes Care Devices Market was valued at USD 26.14 billion in 2021. It is projected to reach USD 45.09 billion by 2028, growing at.
LONDON, Nov. 1, 2022 /PRNewswire/ The Global Diabetes Care Devices Market was valued at USD 26.14 billion in 2021. It is projected to reach USD 45.09 billion by 2028, growing at a CAGR of
/PRNewswire/ The blood glucose monitoring system market size is expected to increase by USD 5.62 billion, at an accelerating CAGR of 9.06 % from 2021 to.
DexCom, Inc. (NASDAQ:NASDAQ:DXCM) Q3 2022 Earnings Conference Call October 27, 2022, 04:30 PM ET Company Participants Sean Christensen - IR Kevin Sayer - Chairman, President and CEO Jereme.